Ping‐Ying Pan

4.8k total citations · 1 hit paper
39 papers, 3.8k citations indexed

About

Ping‐Ying Pan is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Ping‐Ying Pan has authored 39 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 15 papers in Oncology and 5 papers in Genetics. Recurrent topics in Ping‐Ying Pan's work include Immune cells in cancer (20 papers), Immune Cell Function and Interaction (17 papers) and Immunotherapy and Immune Responses (13 papers). Ping‐Ying Pan is often cited by papers focused on Immune cells in cancer (20 papers), Immune Cell Function and Interaction (17 papers) and Immunotherapy and Immune Responses (13 papers). Ping‐Ying Pan collaborates with scholars based in United States, Taiwan and China. Ping‐Ying Pan's co-authors include Shu‐Hsia Chen, Celia M. Divino, Qingsheng Li, Alice I. Sato, Jonathan S. Bromberg, David T. Levy, Bo Huang, Ge Ma, Bingjiao Yin and Junko Ozao‐Choy and has published in prestigious journals such as Journal of Clinical Investigation, The EMBO Journal and Blood.

In The Last Decade

Ping‐Ying Pan

37 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

2006 1.1k citations Bo Huang, Ping‐Ying Pan et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ping‐Ying Pan United States	22	3.1k	1.6k	698	223	197	39	3.8k
Carmela De Santo United Kingdom	25	2.6k 0.8×	1.3k 0.8×	752 1.1×	351 1.6×	172 0.9×	40	3.6k
Vinit Kumar United States	21	2.9k 1.0×	1.6k 1.0×	1.1k 1.5×	489 2.2×	124 0.6×	26	4.1k
Elisa Peranzoni France	18	2.1k 0.7×	1.3k 0.8×	587 0.8×	242 1.1×	71 0.4×	29	2.9k
Diletta Di Mitri Italy	17	2.2k 0.7×	996 0.6×	724 1.0×	254 1.1×	107 0.5×	24	3.3k
Laura Strauss United States	29	3.2k 1.0×	2.0k 1.3×	1.1k 1.6×	542 2.4×	124 0.6×	46	4.5k
Rebecca Liu United States	15	1.7k 0.5×	1.3k 0.8×	854 1.2×	250 1.1×	84 0.4×	20	2.6k
Sydney Gordon United States	8	1.7k 0.6×	1.4k 0.9×	740 1.1×	210 0.9×	105 0.5×	10	2.8k
Steven L. Highfill United States	23	1.7k 0.6×	1.6k 1.0×	719 1.0×	129 0.6×	348 1.8×	86	2.9k
Jason Brayer United States	25	1.7k 0.6×	1.2k 0.7×	818 1.2×	199 0.9×	423 2.1×	67	3.2k
Michele Ardolino Canada	17	2.0k 0.6×	1.4k 0.9×	481 0.7×	193 0.9×	108 0.5×	31	2.7k

Countries citing papers authored by Ping‐Ying Pan

Since Specialization

Citations

This map shows the geographic impact of Ping‐Ying Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping‐Ying Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping‐Ying Pan more than expected).

Fields of papers citing papers by Ping‐Ying Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping‐Ying Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping‐Ying Pan. The network helps show where Ping‐Ying Pan may publish in the future.

Co-authorship network of co-authors of Ping‐Ying Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Ping‐Ying Pan. A scholar is included among the top collaborators of Ping‐Ying Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping‐Ying Pan. Ping‐Ying Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Yitian, Kyeongah Kang, Brian A. Coakley, et al.. (2025). Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4. The EMBO Journal. 44(6). 1866–1883.

Li, Jing, Jie Wang, Bingqian Li, et al.. (2025). Engineering a garlic-derived nanovesicle/microneedle system to boost melanoma immunotherapy through self-amplifying cell death activation and immune remodelling. Chinese Chemical Letters. 111878–111878.

Liu, Yongbin, Dongfang Yu, Xueying Ge, et al.. (2024). Novel platinum therapeutics induce rapid cancer cell death through triggering intracellular ROS storm. Biomaterials. 314. 122835–122835. 10 indexed citations

Butner, Joseph D., Prashant Dogra, Caroline Chung, et al.. (2022). Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study. Cell Death and Disease. 13(5). 485–485. 4 indexed citations

Wang, Lin, Yitian Xu, Kyeongah Kang, et al.. (2022). World Trade Center Dust Exposure Promotes Cancer in PTEN-deficient Mouse Prostates. Cancer Research Communications. 2(6). 518–532. 1 indexed citations

Xu, Yitian, Jose Thaiparambil, Sunny Mai, et al.. (2022). Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell Profiles. Cancer Research Communications. 2(8). 884–893. 9 indexed citations

Kozielski, Anthony J., Wei Qian, Alfred A. Chan, et al.. (2022). Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6. npj Breast Cancer. 8(1). 30–30. 23 indexed citations

Liu, Yongbin, Chaoyang Meng, Junhua Mai, et al.. (2021). The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells. The Journal of Immunology. 207(12). 3131–3140. 5 indexed citations

Zhang, Jilu, Alan W. Hodges, Shu‐Hsia Chen, & Ping‐Ying Pan. (2021). Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases. Cellular Immunology. 362. 104300–104300. 22 indexed citations

10.

Touw, William van der, et al.. (2017). LILRB receptor-mediated regulation of myeloid cell maturation and function. Cancer Immunology Immunotherapy. 66(8). 1079–1087. 117 indexed citations

11.

Ma, Ge, Neil Gildener‐Leapman, Samuel Eisenstein, et al.. (2015). Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy. Clinical Cancer Research. 21(18). 4073–4085. 90 indexed citations

12.

Eisenstein, Samuel, Brian A. Coakley, Karen Briley‐Sæbø, et al.. (2013). Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy. Cancer Research. 73(16). 5003–5015. 64 indexed citations

13.

Yang, Wen‐Chin, et al.. (2013). Polarization and reprogramming of myeloid-derived suppressor cells. Journal of Molecular Cell Biology. 5(3). 207–209. 66 indexed citations

14.

Ma, Ge, Ping‐Ying Pan, Samuel Eisenstein, et al.. (2011). Paired Immunoglobin-like Receptor-B Regulates the Suppressive Function and Fate of Myeloid-Derived Suppressor Cells. Immunity. 34(3). 385–395. 134 indexed citations

15.

Yin, Bingjiao, Ge Ma, Zuping Zhou, et al.. (2010). Myeloid-Derived Suppressor Cells Prevent Type 1 Diabetes in Murine Models. The Journal of Immunology. 185(10). 5828–5834. 145 indexed citations

16.

Huang, Bo, Ping‐Ying Pan, Qingsheng Li, et al.. (2006). Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host. Cancer Research. 66(2). 1123–1131. 1142 indexed citations breakdown →

17.

Xu, Dongping, et al.. (2004). NK and CD8⁺ T cell‐mediated eradication of poorly immunogenic B16‐F10 melanoma by the combined action of IL‐12 gene therapy and 4‐1BB costimulation. International Journal of Cancer. 109(4). 499–506. 82 indexed citations

18.

Pan, Ping‐Ying, Li Yu, Qingsheng Li, et al.. (2003). In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery. Cancer Immunology Immunotherapy. 53(1). 17–25. 38 indexed citations

19.

Kashiwada, Masaki, Cosmas Giallourakis, Ping‐Ying Pan, & Paul B. Rothman. (2001). Immunoreceptor Tyrosine-Based Inhibitory Motif of the IL-4 Receptor Associates with SH2-Containing Phosphatases and Regulates IL-4-Induced Proliferation. The Journal of Immunology. 167(11). 6382–6387. 46 indexed citations

20.

Pan, Ping‐Ying & Paul B. Rothman. (1999). IL-4 receptor mutations. Current Opinion in Immunology. 11(6). 615–620. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact